Related Experiment Video
Updated: Sep 21, 2025

Detection of MicroRNA Expression in the Kidneys of Immunoglobulin A Nephropathic Mice
Published on: July 8, 2020
Anti-glomerular basement membrane disease with IgA nephropathy: A case report
Chuan Guo1, Ming Ye1, Shen Li1
1Department of Nephrology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China.
Anti-glomerular basement membrane (GBM) disease coexisting with Immunoglobulin A (IgA) nephropathy is a rare condition. Treatment with corticosteroids and cyclophosphamide stabilized renal function and improved symptoms in a recent case study.
Area of Science:
- Nephrology
- Autoimmunology
- Pathology
Background:
- Anti-glomerular basement membrane (GBM) disease is a rare autoimmune disorder causing acute nephritis and potential pulmonary hemorrhage.
- Coexistence of anti-GBM disease with Immunoglobulin A (IgA) nephropathy is exceptionally rare, presenting unique clinical characteristics and prognoses.
- This report details a specific case illustrating the combined presentation of these two distinct kidney diseases.
Observation:
- A 49-year-old male presented with hematuria, proteinuria, and mildly elevated creatinine.
- Renal biopsy and elevated anti-GBM antibody titers confirmed a dual diagnosis of anti-GBM disease and IgA nephropathy.
- The patient received treatment combining corticosteroids and cyclophosphamide.
Findings:
- The combined condition of anti-GBM disease and IgA nephropathy demonstrated a more favorable prognosis compared to isolated anti-GBM disease.
- Following treatment, the patient exhibited stabilized serum creatinine levels and moderate improvement in hematuria and proteinuria over six months.
- The therapeutic regimen of corticosteroids and cyclophosphamide proved effective in managing this rare dual kidney pathology.
Implications:
- This case suggests that combined anti-GBM disease and IgA nephropathy may have a better prognosis than previously understood.
- The efficacy of immunosuppressive therapy, including corticosteroids and cyclophosphamide, highlights a potential treatment pathway for this rare condition.
- Further research is warranted to develop advanced diagnostic methods for differentiating the origins of renal crescents in such complex cases, potentially refining treatment strategies.
More Related Videos
14:18Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy
Published on: October 13, 2023
10:27Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
Published on: December 15, 2011